Status:
COMPLETED
Isokinetic Performance After Cruciate-substituting Ultra-congruent and Posterior Stabilized Total Knee Arthroplasties
Lead Sponsor:
Aksaray University Training and Research Hospital
Conditions:
Osteoarthritis, Knee
Knee Arthritis
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
The choice between ultra-congruent (UC) insert or posterior cruciate ligament-stabilized (PS) insert in posterior cruciate ligament (PCL) sacrificing total knee arthroplasty (TKA) remains debatable. D...
Detailed Description
Eligibility of all patients between 55 and 80 years, scheduled to undergo unilateral TKA on for primary knee osteoarthritis will be evaluated. The exclusion criteria are rheumatological joint diseases...
Eligibility Criteria
Inclusion
- Age between 55 and 80 years
- Scheduled to undergo unilateral TKA on for primary knee osteoarthritis
Exclusion
- Rheumatological joint diseases
- Previous knee surgery
- Neuromuscular diseases
- Bilateral TKA
- Insufficiency of collateral ligaments
Key Trial Info
Start Date :
January 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04419311
Start Date
January 19 2017
End Date
March 30 2018
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aksaray University Training and Research Hospital
Aksaray, Turkey (Türkiye), 68200